Fig. 1: Semi-logarithmic plots of SARS-CoV-2 spike antibodies after two doses of BNT162b2 vaccine. | npj Vaccines

Fig. 1: Semi-logarithmic plots of SARS-CoV-2 spike antibodies after two doses of BNT162b2 vaccine.

From: Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination

Fig. 1

a Box plots of all available cases (N = 657; cases for which data were available only at week zero were excluded); logarithmic means stratified by b antibodies at week 3, c age group, and d sex. Error bars indicate 95% confidence intervals. b The cutoffs for antibodies at week 3 were determined based on the 25th, 50th, and 75th percentiles. All the demonstrated antibody titers were anti-receptor-binding domain IgG.

Back to article page